These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 31731485)

  • 1. Autophagic- and Lysosomal-Related Biomarkers for Parkinson's Disease: Lights and Shadows.
    Xicoy H; Peñuelas N; Vila M; Laguna A
    Cells; 2019 Oct; 8(11):. PubMed ID: 31731485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.
    Murphy KE; Gysbers AM; Abbott SK; Tayebi N; Kim WS; Sidransky E; Cooper A; Garner B; Halliday GM
    Brain; 2014 Mar; 137(Pt 3):834-48. PubMed ID: 24477431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies.
    Xilouri M; Brekk OR; Stefanis L
    Mov Disord; 2016 Feb; 31(2):178-92. PubMed ID: 26813776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction.
    Bellomo G; Paciotti S; Gatticchi L; Parnetti L
    Mov Disord; 2020 Jan; 35(1):34-44. PubMed ID: 31729779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Role of the Lysosome in Parkinson's Disease.
    Navarro-Romero A; Montpeyó M; Martinez-Vicente M
    Cells; 2020 Nov; 9(11):. PubMed ID: 33147750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal alterations in peripheral blood mononuclear cells of Parkinson's disease patients.
    Papagiannakis N; Xilouri M; Koros C; Stamelou M; Antonelou R; Maniati M; Papadimitriou D; Moraitou M; Michelakakis H; Stefanis L
    Mov Disord; 2015 Nov; 30(13):1830-4. PubMed ID: 26769460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics.
    Senkevich K; Gan-Or Z
    Parkinsonism Relat Disord; 2020 Apr; 73():60-71. PubMed ID: 31761667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocerebrosidase deficits in sporadic Parkinson disease.
    Murphy KE; Halliday GM
    Autophagy; 2014 Jul; 10(7):1350-1. PubMed ID: 24915553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease.
    Matrone C; Dzamko N; Madsen P; Nyegaard M; Pohlmann R; Søndergaard RV; Lassen LB; Andresen TL; Halliday GM; Jensen PH; Nielsen MS
    PLoS One; 2016; 11(8):e0160501. PubMed ID: 27509067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Consequences of GBA Deficiency in the Autophagy-Lysosome System in Parkinson's Disease Associated with GBA.
    Pradas E; Martinez-Vicente M
    Cells; 2023 Jan; 12(1):. PubMed ID: 36611984
    [No Abstract]   [Full Text] [Related]  

  • 12. Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links.
    Moors T; Paciotti S; Chiasserini D; Calabresi P; Parnetti L; Beccari T; van de Berg WD
    Mov Disord; 2016 Jun; 31(6):791-801. PubMed ID: 26923732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal impairment in Parkinson's disease.
    Dehay B; Martinez-Vicente M; Caldwell GA; Caldwell KA; Yue Z; Cookson MR; Klein C; Vila M; Bezard E
    Mov Disord; 2013 Jun; 28(6):725-32. PubMed ID: 23580333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.
    Fernandes HJ; Hartfield EM; Christian HC; Emmanoulidou E; Zheng Y; Booth H; Bogetofte H; Lang C; Ryan BJ; Sardi SP; Badger J; Vowles J; Evetts S; Tofaris GK; Vekrellis K; Talbot K; Hu MT; James W; Cowley SA; Wade-Martins R
    Stem Cell Reports; 2016 Mar; 6(3):342-56. PubMed ID: 26905200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.
    Huebecker M; Moloney EB; van der Spoel AC; Priestman DA; Isacson O; Hallett PJ; Platt FM
    Mol Neurodegener; 2019 Nov; 14(1):40. PubMed ID: 31703585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
    Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.
    Wong YC; Krainc D
    Mov Disord; 2016 Nov; 31(11):1610-1618. PubMed ID: 27619775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
    Blanz J; Saftig P
    J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GBA deficiency promotes SNCA/α-synuclein accumulation through autophagic inhibition by inactivated PPP2A.
    Du TT; Wang L; Duan CL; Lu LL; Zhang JL; Gao G; Qiu XB; Wang XM; Yang H
    Autophagy; 2015; 11(10):1803-20. PubMed ID: 26378614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lysosomal lair for a pathogenic protein pair.
    Dawson TM; Dawson VL
    Sci Transl Med; 2011 Jul; 3(91):91ps28. PubMed ID: 21753118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.